Literature DB >> 4065403

Differentiation between carrier-bound forms of non-suppressible insulin-like activity (NSILA) in serum.

H J Cornell, M Bistrin, A C Herington.   

Abstract

Gel-permeation chromatography of serum on Sephacryl S-300 at pH 7.4 has shown that NSILA was detected over a range of MW 50,000-400,000 with a peak at about MW 200,000. When fractions from the above chromatography were rechromatographed on Sephadex G-75 at pH 2.4 major amounts of acid-stable NSILA were found in a fraction of MW 200,000-600,000 (77% of the fraction NSILA or 28% of total serum NSILA). Further evidence was obtained for the presence of an active acid-dissociable complex in serum. This was present in both the MW 100,000-200,000 and 35,000-100,000 fractions and corresponded to 37% of total serum NSILA. Con-A Sepharose affinity chromatography of the serum fractions from Sephacryl S-300 chromatography, followed by Sephadex G-75 chromatography under acid conditions, showed that the acid-stable complex was consistently found in weakly bound materials. The active acid-dissociable complex was found in the bound fractions, especially in the Sephacryl S-300 pool of MW 35,000-100,000. Low MW NSILA (less than 15,000) was also released on acid treatment from an otherwise inactive high MW complex(es) of MW 35,000-600,000. This complex was not bound by Con-A Sepharose.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 4065403     DOI: 10.1016/0020-711x(85)90246-0

Source DB:  PubMed          Journal:  Int J Biochem        ISSN: 0020-711X


  2 in total

1.  Recognition of insulin-like-growth-factor-binding proteins in serum and amniotic fluid by an antiserum against a low-molecular-mass insulin-like-growth-factor-inhibitor/binding protein.

Authors:  G T Ooi; A C Herington
Journal:  Biochem J       Date:  1990-05-01       Impact factor: 3.857

2.  Preferential association of the insulin-like growth factors I and II with metabolically inactive and active carrier-bound complexes in serum.

Authors:  H J Cornell; G Enberg; A C Herington
Journal:  Biochem J       Date:  1987-02-01       Impact factor: 3.857

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.